Lithium treatment enhances estradiol-induced proliferation and hyperplasia formation in the uterus of mice

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 114, Issue 1, 2004, Pages 83-91

  Gunin, Andrei G ^a   Emelianov, Vladimir U ^a   Mironkin, Igor U ^a   Morozov, Mikhail P ^a   Tolmachev, Alexei S ^a  

^a CHUVASH STATE UNIVERSITY   (Russian Federation)

Author keywords

Endometrial hyperplasia; Estrogen receptors; Estrogens; Glycogen synthase kinase 3 ; Lithium; Proliferation; Uterus; Catenin

Indexed keywords

BETA CATENIN; ESTRADIOL DIPROPIONATE; ESTROGEN RECEPTOR ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; LITHIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOMETRIUM HYPERPLASIA; EPITHELIUM CELL; FEMALE; MITOSIS; MORPHOGENESIS; MOUSE; MYOMETRIUM; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; STROMA; UTERUS;

EID: 1942472451     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2003.09.023     Document Type: Article

References (33)

1. Bigsby R.M. Control of growth and differentiation of the endometrium: the role of tissue interactions. Ann. N. Y. Acad. Sci. 955:2002;110-117.
2. Martin L., Finn C.A., Trinder G. Hypertrophy and hyperplasia in the mouse uterus after oestrogen treatment: an autoradiographic study. J. Endocrinol. 56:1973;133-144.
3. Emons G., Fleckenstein G., Hinney B., Huschmand A., Heyl W. Hormonal interactions in endometrial cancer. Endocr. Relat. Cancer. 7:2000;227-242.
4. Akhmedkhanov A., Zeleniuch-Jacquotte A., Toniolo P. Role of exogenous and endogenous hormones in endometrial cancer: review of the evidence and research perspectives. Ann. N. Y. Acad. Sci. 943:2001;296-315.
5. Miller JR. Wnts. Genome Biol 2002;3:1-15.
6. Schlesinger A., Shelton C.A., Maloof J.N., Meneghini M., Bowerman B. Wnt pathway components orient a mitotic spindle in the early Caenorhabditis elegans embryo without requiring gene transcription in the responding cell. Genes Dev. 13:1999;2028-2038.
7. Morin P.J. Beta-catenin signaling and cancer. Bioessays. 21:1999;1021-1030.
8. Miyamoto S., Baba H., Kuroda S., Kaibuchi K., Fukuda T., Maehara Y.et al. Changes in E-cadherin associated with cytoplasmic molecules in well and poorly differentiated endometrial cancer. Br. J. Cancer. 83:2000;1168-1175.
9. Fukuhara K., Kariya M., Kita M., Shime H., Kanamori T., Kosaka C.et al. Secreted frizzled related protein 1 is overexpressed in uterine leiomyomas, associated with a high estrogenic environment and unrelated to proliferative activity. J. Clin. Endocrinol. Metab. 87:2002;1729-1736.
10. Kitajewski J., Sassoon D. The emergence of molecular gynecology: homeobox and Wnt genes in the female reproductive tract. Bioessays. 22:2000;902-910.
11. Heikkila M., Peltoketo H., Vainio S. Wnts and the female reproductive system. J. Exp. Zool. 290:2001;616-623.
12. Fujimoto J., Ichigo S., Hori M., Tamaya T. Expressions of E-cadherin and alpha- and beta-catenin mRNAs in uterine endometrial cancers. Eur. J. Gynaecol. Oncol. 19:1998;78-81.
13. Fujimoto J., Ichigo S., Hori M., Tamaya T. Alteration of E-cadherin, alpha- and beta-catenin mRNA expression in human uterine endometrium during the menstrual cycle. Gynecol. Endocrinol. 10:1996;187-191.
14. Rossig L., Badorff C., Holzmann Y., Zeiher A.M., Dimmeler S. Glycogen synthase kinase-3 couples AKT-dependent signaling to the regulation of p21Cip1 degradation. J. Biol. Chem. 277:2002;9684-9689.
15. Van Noort M., Meeldijk J., Van Der Zee R., Destree O., Clevers H. Wnt signaling controls the phosphorylation status of beta-catenin. J. Biol. Chem. 277:2002;17901-17905.
16. Chen R.H., Ding W.V., McCormick F. Wnt signaling to beta-catenin involves two interactive components. Glycogen synthase kinase-3beta inhibition and activation of protein kinase C. J. Biol. Chem. 275:2000;17894-17899.
17. Gunin A.G., Sharov A.A., Nikolaev D.V. Two month glucocorticoid treatment increases estradiol-induced stromal and myometrial cell proliferation in the uterus of ovariectomized rats. Eur. J. Obstet. Gynecol. Reprod. Biol. 88:2000;171-179.
18. Scully RE, Bonfiglio TA, Kurman RJ, Silverberg SG, Wilkinson EJ. Histological typing of female genital tract tumours (International histological Classification of Tumours), 2nd ed. Geneva: WHO; 1994. p. 13-18.
19. Gunin A.G., Mashin I.N., Zakharov D.A. Proliferation, mitosis orientation and morphogenetic changes in the uterus of mice following chronic treatment with both estrogen and glucocorticoid hormones. J. Endocrinol. 169:2001;23-31.
20. Takahashi M., Tomizawa K., Ishiguro K. Distribution of tau protein kinase I/glycogen synthase kinase-3beta, phosphatases 2A and 2B, and phosphorylated tau in the developing rat brain. Brain Res. 857:2000;193-206.
21. Gunin A.G., Emelianov V., Tolmachev A.S. Effect of adrenocorticotrophic hormone on the development of oestrogen-induced changes and hyperplasia formation in the mouse uterus. Reproduction. 123:2002;601-611.
22. Couse J.F., Korach K.S. Estrogen receptor null mice: what have we learned and where will they lead us? Endocr. Rev. 20:1999;358-417.
23. Deligdisch L. Hormonal pathology of the endometrium. Mod. Pathol. 13:2000;285-294.
24. Nephew K.P., Long X., Osborne E., Burke K.A., Ahluwalia A., Bigsby R.M. Effect of estradiol on estrogen receptor expression in rat uterine cell types. Biol. Reprod. 62:2000;168-177.
25. Ing N.H., Ott T.L. Estradiol up-regulates estrogen receptor-alpha messenger ribonucleic acid in sheep endometrium by increasing its stability. Biol. Reprod. 60:1999;134-139.
26. Sivridis E., Giatromanolaki A., Koukourakis M., Anastasiadis P. Endometrial carcinoma: association of steroid hormone receptor expression with low angiogenesis and bcl-2 expression. Virchows Arch. 438:2001;470-477.
27. Klotz D.M., Hewitt S.C., Ciana P., Raviscioni M., Lindzey J.K., Foley J.et al. Requirement of estrogen receptor-alpha in insulin-like growth factor-1 (IGF-1)-induced uterine responses and in vivo evidence for IGF-1/estrogen receptor cross-talk. J. Biol. Chem. 277:2002;8531-8537.
28. Rogers I., Varmuza S. LiCl disrupts axial development in mouse but does not act through the beta-catenin/Lef-1 pathway. Mol. Reprod. Dev. 55:2000;387-392.
29. Sheldahl L.C., Park M., Malbon C.C., Moon R.T. Protein kinase C is differentially stimulated by Wnt and Frizzled homologs in a G-protein-dependent manner. Curr. Biol. 9:1999;695-698.
30. Hedgepeth C.M., Conrad L.J., Zhang J., Huang H.C., Lee V.M., Klein P.S. Activation of the Wnt signaling pathway: a molecular mechanism for lithium action. Dev. Biol. 185:1997;82-91.
31. Welshons W.V., Engler K.S., Taylor J.A., Grady L.H., Curran E.M. Lithium-stimulated proliferation and alteration of phosphoinositide metabolites in MCF-7 human breast cancer cells. J. Cell Physiol. 165:1995;134-144.
32. Weiss D.J., Gurpide E. Regulation of phosphoinositide hydrolysis in transformed human endometrial cells. Endocrinology. 123:1988;981-990.
33. Taylor J.A., Grady L.H., Engler K.S., Welshons W.V. Relationship of growth stimulated by lithium, estradiol, and EGF to phospholipase C activity in MCF-7 human breast cancer cells. Breast Cancer Res. Treat. 34:1995;265-277.